Appeals court broadens Samsung Biologics strike ban, curbs union leverage in Korea
Appeals judges side with management, classifying early bioprocess steps as security work and narrowing strike impact The likelihood that Samsung Biologics(207940), a CDMO in biopharmaceuticals, will face production disruptions due to a union strike has decreased. The court, unlike in…